Treat-to-target in gout management? Comment on the article by FitzGerald et al

被引：0

作者：

Kolber, Michael R. ^{[1
]}

Ton, Joey ^{[1
]}

机构：

[1] Univ Alberta, Edmonton, AB, Canada

来源：

ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷 / 03期

关键词：

EFFICACY; URATE;

D O I：

10.1002/art.41523

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：543 / 544

页数：2

共 50 条

[1] Determinants of achieving serum urate goal with treat-to-target urate-lowering therapy in gout: comment on the article by Helget et al
Small, Daniel
ARTHRITIS & RHEUMATOLOGY, 2024, 76 (11) : 1698 - 1698
[2] Classifying remission in rheumatoid arthritis treat-to-target studies: comment on the article by Norvang et al
Xie, Wenhui
Zhang, Zhuoli
ARTHRITIS & RHEUMATOLOGY, 2020, 72 (08) : 1406 - 1407
[3] Response to the 2020 American College of Rheumatology Guideline for the Management of Gout: Comment on the Article by FitzGerald et al
Lipsky, Peter E.
Edwards, N. Lawrence
Fields, Theodore R.
Keenan, Robert T.
Mandell, Brian F.
Schlesinger, Naomi
ARTHRITIS CARE & RESEARCH, 2020, 72 (10) : 1506 - 1507
[4] Determinants of achieving serum urate goal with treat-to-target urate-lowering therapy in gout: comment on the article by Helget et al Reply
Dellaripa, Paul F.
ARTHRITIS & RHEUMATOLOGY, 2024, 76 (11) : 1696 - 1697
[5] Response to the 2020 American College of Rheumatology guideline for the management of gout: comment on the article by FitzGerald et al Reply
FitzGerald, John
Brignardello-Petersen, Romina
Dalbeth, Nicola
Mikuls, Ted
Neogi, Tuhina
Guyatt, Gordon
ARTHRITIS CARE & RESEARCH, 2020, 72 (10) : 1507 - 1508
[6] Uricaemia as a surrogate endpoint in gout trials and the treat-to-target approach for gout management
Bardin, Thomas
Richette, Pascal
LANCET RHEUMATOLOGY, 2022, 4 (01): : E7 - E8
[7] To switch or not switch febuxostat: comment on the article by FitzGerald et al
Xu, Chuanhui
ARTHRITIS & RHEUMATOLOGY, 2021, 73 (02) : 359 - 360
[8] Gout: thoughts about a treat-to-target programme
Braun, J.
Smolen, J. S.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : S142 - S144
[9] 'Treat-to-target' with allopurinol is feasible in patients with gout
Shreeya Nanda
Nature Reviews Rheumatology, 2011, 7 (1) : 3 - 3
[10] Treat-to-target urate lowering therapy for gout
Thorley, Jennifer
LANCET RHEUMATOLOGY, 2020, 2 (09): : E526 - E526

← 1 2 3 4 5 →